for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Thermo Fisher Scientific Inc.

TMO.N

Latest Trade

294.84USD

Change

-0.12(-0.04%)

Volume

105,442

Today's Range

293.90

 - 

296.72

52 Week Range

208.34

 - 

305.43

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
294.96
Open
293.96
Volume
105,442
3M AVG Volume
31.22
Today's High
296.72
Today's Low
293.90
52 Week High
305.43
52 Week Low
208.34
Shares Out (MIL)
400.48
Market Cap (MIL)
117,223.30
Forward P/E
23.88
Dividend (Yield %)
0.26

Next Event

Q3 2019 Thermo Fisher Scientific Inc Earnings Release

Latest Developments

More

Evoke Pharma Completed Manufacturing Commercial Scale Batches Of Product Candidate Gimoti

Thermo Fisher Scientific Elects New Director To Board

Thermo Fisher Qtrly Adj EPS $3.04

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Industry

Medical Equipment & Supplies

Contact Info

168 3rd Ave

+1.781.6221000

https://www.thermofisher.com/

Executive Leadership

Jim P. Manzi

Independent Chairman of the Board

Marc N. Casper

President, Chief Executive Officer, Director

Stephen Williamson

Chief Financial Officer, Senior Vice President

Mark P. Stevenson

Chief Operating Officer, Executive Vice President

Michael A. Boxer

Senior Vice President, General Counsel

Key Stats

1.67 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

18.3K

2017

20.9K

2018

24.4K

2019(E)

25.4K
EPS (USD)

2016

8.270

2017

9.490

2018

11.120

2019(E)

12.256
Price To Earnings (TTM)
33.17
Price To Sales (TTM)
4.71
Price To Book (MRQ)
4.08
Price To Cash Flow (TTM)
20.16
Total Debt To Equity (MRQ)
66.27
LT Debt To Equity (MRQ)
58.00
Return on Investment (TTM)
7.14
Return on Equity (TTM)
6.29

Latest News

Thermo Fisher, Danaher among firms competing for KKR's LGC Group: Bloomberg

Medical device makers Thermo Fisher Scientific Inc <TMO.N> and Danaher Corp <DHR.N> have expressed interest in KKR & Co's <KKR.N> potential sale of its scientific measurement and testing company LGC Group, Bloomberg reported on Friday.

Thermo Fisher misses organic revenue growth estimates, shares fall

Thermo Fisher Scientific Inc <TMO.N> missed Wall Street estimates for quarterly organic revenue growth on Wednesday, hurt by an outage at one of its data centers, sending the company's shares down as much as 4.9%.

Thermo Fisher raises full-year forecasts as life sciences drives quarterly profit

Thermo Fisher Scientific Inc reported second-quarter profit that beat Wall Street estimates and raised its 2019 forecast for sales and profit on Wednesday, helped by a 9% rise in sales at its life sciences unit.

Thermo Fisher scraps Roper deal after U.K. antitrust hurdle

Thermo Fisher Scientific Inc and Roper Technologies Inc said on Monday they have mutually agreed to terminate Thermo Fisher's deal to buy Roper's unit Gatan Inc owing to challenges in obtaining regulatory approval in the United Kingdom.

Thermo Fisher, Roper agree to terminate $925 million deal

Thermo Fisher Scientific Inc and Roper Technologies Inc on Monday said they have mutually agreed to terminate Thermo Fisher's deal to buy Roper's unit Gatan Inc.

Thermo Fisher raises 2019 forecasts, beats Q1 profit estimates

Thermo Fisher Scientific Inc on Wednesday raised its 2019 forecasts for adjusted profit and revenue on the back of its $1.7 billion deal to buy Brammer Bio, and beat the average analyst estimate for first-quarter profit.

Thermo Fisher to acquire Brammer Bio in $1.7 billion deal

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, said on Sunday it has agreed to buy Brammer Bio in a roughly $1.7 billion cash deal.

Thermo Fisher to acquire Brammer Bio in $1.7 bln deal

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, said on Sunday it has agreed to buy Brammer Bio in a roughly $1.7 billion cash deal.

Thermo Fisher to sell pathology unit for $1.14 billion

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, will sell its anatomical pathology business for $1.14 billion in cash, the company said on Monday.

UK competition watchdog to take a deeper look at Thermo Fisher Roper deal

Thermo Fisher Scientific Inc's proposed $925 million acquisition of Roper Technologies Inc's unit will be referred for a deeper phase two investigation, Britain's competition watchdog said on Monday.

UK competition watchdog puts Thermo Fisher-Roper deal under the microscope

Britain's competition watchdog said on Wednesday Thermo Fisher Scientific Inc's <TMO.N> $925 million acquisition of Roper Technologies Inc's <ROP.N> unit Gatan raised concerns that prices of microscopes could go up and quality could suffer.

UK competition watchdog puts Thermo Fisher-Roper deal under the microscope

Britain's competition watchdog said on Wednesday Thermo Fisher Scientific Inc's $925 million acquisition of Roper Technologies Inc's unit Gatan raised concerns that prices of specialist microscopes could go up and quality could decline.

Thermo Fisher raises forecast after third-quarter profit beat

Thermo Fisher Scientific Inc <TMO.N> reported a better-than-expected quarterly profit on Wednesday on higher demand for its laboratory products and the world's largest scientific instruments maker raised its full-year forecast.

Thermo Fisher raises forecast after second-quarter beat

Thermo Fisher Scientific Inc <TMO.N> posted a better-than-expected quarterly profit as its laboratory products division received a boost from a recent acquisition, and the company raised its 2018 forecast.

Thermo Fisher to buy Roper Technologies unit for $925 million

Thermo Fisher Scientific Inc <TMO.N>, the world's largest maker of scientific instruments, said on Thursday it would buy IT services provider Roper Technologies Inc's <ROP.N> unit Gatan Inc for about $925 million in cash.

Thermo Fisher to buy Roper Technologies unit for $925 mln

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, said on Thursday it would buy Roper Technologies Inc's unit Gatan Inc for about $925 million in cash.

BRIEF-Thermo Fisher Scientific Sets Quarterly Cash Dividend Of $0.17 Per Share

* SETS QUARTERLY CASH DIVIDEND OF $0.17PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Omega Advisors Takes Share Stake In UnitedHealth, Bristol-Myers Squibb

* OMEGA ADVISORS DISSOLVES SHARE STAKE IN AMERICAN AIRLINES - SEC FILING

BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific

* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC

BRIEF-Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target Test

* THERMO FISHER SCIENTIFIC SIGNS NEW AGREEMENTS TO EXPAND ONCOMINE DX TARGET TEST

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up